| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Beck RP et al. | Thyroid function studies in different phases of the menstrual cycle and in women receiving norethindrone with and without estrogen. | 1972 | Am. J. Obstet. Gynecol. | pmid:4110544 |
| MENDEL EB and HABERMAN S | COMPARISON OF SEROLOGICAL, FROG, AND HORMONE WITHDRAWAL BLEEDING TESTS FOR EARLY PREGNANCY. | 1964 | Am. J. Obstet. Gynecol. | pmid:14241509 |
| Beyer G and Behrman SJ | Myometrial activity and the IUCD. 3. Effect of contraceptive pills. | 1970 | Am. J. Obstet. Gynecol. | pmid:5410390 |
| McLean FW et al. | Relationship between the oral contraceptive and folic acid metabolism. Serum folate concentrations. | 1969 | Am. J. Obstet. Gynecol. | pmid:4892225 |
| Engmann L et al. | Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study. | 1999 | Am. J. Obstet. Gynecol. | pmid:10486466 |
| Diddle AW et al. | Oral contraceptive medication: a prolonged experience. | 1966 | Am. J. Obstet. Gynecol. | pmid:5939017 |
| Levin JH et al. | Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells. | 1990 | Am. J. Obstet. Gynecol. | pmid:2147816 |
| Rowan JP | "Estrophasic" dosing: A new concept in oral contraceptive therapy. | 1999 | Am. J. Obstet. Gynecol. | pmid:9988834 |
| Dören M et al. | Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2000 | Am. J. Obstet. Gynecol. | pmid:10992176 |
| Louv WC et al. | Oral contraceptive use and the risk of chlamydial and gonococcal infections. | 1989 | Am. J. Obstet. Gynecol. | pmid:2916625 |
| Chihal HJ et al. | Estrogen potency of oral contraceptive pills. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115120 |
| Reisman H et al. | A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol. | 1999 | Am. J. Obstet. Gynecol. | pmid:10561675 |
| Brakman P et al. | Effects of different systemic contraceptives on blood fibrinolysis. | 1970 | Am. J. Obstet. Gynecol. | pmid:5410044 |
| Shojania AM et al. | The effect of oral contraceptives on folate metabolism. | 1971 | Am. J. Obstet. Gynecol. | pmid:5166389 |
| Caillouette JC and Koehler AL | Phasic contraceptive pills and functional ovarian cysts. | 1987 | Am. J. Obstet. Gynecol. | pmid:3296761 |
| Rabinovici J et al. | Acute abdominal condition caused by retrograde bleeding in a postmenopausal patient on estrogen-progestogen therapy. | 1985 | Am. J. Obstet. Gynecol. | pmid:4061537 |
| Pochi PE and Strauss JS | Lack of androgen effect on human sebaceous glands with low-dosage norethindrone. | 1965 | Am. J. Obstet. Gynecol. | pmid:5843402 |
| Pria SD et al. | Current thoughts on the management of dysfunctional uterine bleeding. | 1969 | Am. J. Obstet. Gynecol. | pmid:5360247 |
| Karim M and el-Mahgoub S | Conception control by cyclic injections of norethisterone enanthate and estradiol unducelate. | 1971 | Am. J. Obstet. Gynecol. | pmid:5563241 |
| Aronson HB et al. | Effect of oral contraceptives on blood viscosity. | 1971 | Am. J. Obstet. Gynecol. | pmid:5558983 |
| Munk-Jensen N et al. | Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial. | 1994 | Am. J. Obstet. Gynecol. | pmid:8030688 |
| Crist T et al. | Lactation following lobectomy. | 1971 | Am. J. Obstet. Gynecol. | pmid:5563240 |
| Di Paola G et al. | Oral contraceptives and carbohydrate metabolism. | 1968 | Am. J. Obstet. Gynecol. | pmid:4172445 |
| Givens JR et al. | The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women. | 1976 | Am. J. Obstet. Gynecol. | pmid:1251854 |
| Price TM et al. | Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. | 1993 | Am. J. Obstet. Gynecol. | pmid:8498419 |
| Braselton WE et al. | Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage. | 1979 | Am. J. Obstet. Gynecol. | pmid:369375 |
| Connell EB and Connell JT | C-reactive protein in pregnancy and contraception. | 1971 | Am. J. Obstet. Gynecol. | pmid:4104957 |
| WHARTON LR and SCOTT RB | EXPERIMENTAL PRODUCTION OF GENITAL LESIONS WITH NORETHINDRONE. | 1964 | Am. J. Obstet. Gynecol. | pmid:14198966 |
| Darney PD | Hormonal implants: contraception for a new century. | 1994 | Am. J. Obstet. Gynecol. | pmid:8178903 |
| Dodek OI and Kotz HL | Syndrome of anovulation following the oral contraceptives. | 1967 | Am. J. Obstet. Gynecol. | pmid:4951888 |
| O'Neill RT | Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. | 1970 | Am. J. Obstet. Gynecol. | pmid:4952585 |
| Moawad AH and Bengtsson LP | In vivo studies of the motility pattern of the nonpregnant human uterus. 3. The effect of anovulatory pills. | 1968 | Am. J. Obstet. Gynecol. | pmid:5690296 |
| Goldzieher JW et al. | Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. | 1971 | Am. J. Obstet. Gynecol. | pmid:4108553 |
| Morcos F et al. | The effect of norethindrone with and without estrogen on serum immunoreactive luteinizing hormone secretion. | 1972 | Am. J. Obstet. Gynecol. | pmid:5060380 |
| McShane PM et al. | Thrombotic thrombocytopenic purpura associated with oral contraceptives: a case report. | 1983 | Am. J. Obstet. Gynecol. | pmid:6681940 |
| Gambrell RD | Use of progestogen therapy. | 1987 | Am. J. Obstet. Gynecol. | pmid:3578452 |
| Djerassi C et al. | Steroids LIV. Synthesis of 19-nor-17alpha-ethynyltestosterone and 19-nor-17alpha-methyltestosterone. 1954. | 2006 | Am. J. Obstet. Gynecol. | pmid:16389045 |
| Portman DJ et al. | A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone. | 2003 | Am. J. Obstet. Gynecol. | pmid:12592236 |
| Vardy MD et al. | The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model. | 2005 | Am. J. Obstet. Gynecol. | pmid:15902188 |
| JACOBSON BD | Hazards of northindrome therapy during pregnancy. | 1962 | Am. J. Obstet. Gynecol. | pmid:13964346 |
| Saleh WA et al. | A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels. | 1993 | Am. J. Obstet. Gynecol. | pmid:8317516 |
| Madsen JS et al. | Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. | 2002 | Am. J. Obstet. Gynecol. | pmid:12114885 |
| Riis BJ et al. | Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review. | 2002 | Am. J. Obstet. Gynecol. | pmid:12389012 |
| Djerassi C | Chemical birth of the pill. 1992. | 2006 | Am. J. Obstet. Gynecol. | pmid:16389046 |
| Pritchard JA and Pritchard SA | Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension. | 1977 | Am. J. Obstet. Gynecol. | pmid:607805 |
| Damber MG et al. | A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives. | 1976 | Am. J. Obstet. Gynecol. | pmid:55075 |
| Chang MC | Development of the oral contraceptives. | 1978 | Am. J. Obstet. Gynecol. | pmid:356615 |
| Spellacy WN et al. | Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months. | 1988 | Am. J. Obstet. Gynecol. | pmid:3052079 |
| Toddywalla VS et al. | Effect of contraceptive steroids on human lactation. | 1977 | Am. J. Obstet. Gynecol. | pmid:835620 |
| GOODRICH SM and WOOD JE | PERIPHERAL VENOUS DISTENSIBILITY AND VELOCITY OF VENOUS BLOOD FLOW DURING PREGNANCY OR DURING ORAL CONTRACEPTIVE THERAPY. | 1964 | Am. J. Obstet. Gynecol. | pmid:14233661 |